Skip to main content
Top
Published in: BMC Medical Imaging 1/2020

01-12-2020 | Computed Tomography | Research article

Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging

Authors: Xue Sha, Guanzhong Gong, Qingtao Qiu, Jinghao Duan, Dengwang Li, Yong Yin

Published in: BMC Medical Imaging | Issue 1/2020

Login to get access

Abstract

Background

We aimed to develop radiomic models based on different phases of computed tomography (CT) imaging and to investigate the efficacy of models for diagnosing mediastinal metastatic lymph nodes (LNs) in non-small cell lung cancer (NSCLC).

Methods

Eighty-six NSCLC patients were enrolled in this study, and we selected 231 mediastinal LNs confirmed by pathology results as the subjects which were divided into training (n = 163) and validation cohorts (n = 68). The regions of interest (ROIs) were delineated on CT scans in the plain phase, arterial phase and venous phase, respectively. Radiomic features were extracted from the CT images in each phase. A least absolute shrinkage and selection operator (LASSO) algorithm was used to select features, and multivariate logistic regression analysis was used to build models. We constructed six models (orders 1–6) based on the radiomic features of the single- and dual-phase CT images. The performance of the radiomic model was evaluated by the area under the receiver operating characteristic curve (AUC), sensitivity, specificity, accuracy, positive predictive value (PPV) and negative predictive value (NPV).

Results

A total of 846 features were extracted from each ROI, and 10, 9, 5, 2, 2, and 9 features were chosen to develop models 1–6, respectively. All of the models showed excellent discrimination, with AUCs greater than 0.8. The plain CT radiomic model, model 1, yielded the highest AUC, specificity, accuracy and PPV, which were 0.926 and 0.925; 0.860 and 0.769; 0.871 and 0.882; and 0.906 and 0.870 in the training and validation sets, respectively. When the plain and venous phase CT radiomic features were combined with the arterial phase CT images, the sensitivity increased from 0.879 and 0.919 to 0.949 and 0979 and the NPV increased from 0.821 and 0.789 to 0.878 and 0.900 in the training group, respectively.

Conclusions

All of the CT radiomic models based on different phases all showed high accuracy and precision for the diagnosis of LN metastasis (LNM) in NSCLC patients. When combined with arterial phase CT, the sensitivity and NPV of the model was be further improved.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Center MM, Desantis C, Ward EM. Global patterns of cancer incidence and mortality rates an trends. Cancer Epidemiol Biomark Prev. 2010;19(8):1893–07.CrossRef Jemal A, Center MM, Desantis C, Ward EM. Global patterns of cancer incidence and mortality rates an trends. Cancer Epidemiol Biomark Prev. 2010;19(8):1893–07.CrossRef
2.
go back to reference Abramyuk A, Appold S, ZöPhel K, Hietschold V, Baumann M, Abolmaali N. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy-a retrospective study. Lung Cancer. 2012;78(2):148–52.PubMedCrossRef Abramyuk A, Appold S, ZöPhel K, Hietschold V, Baumann M, Abolmaali N. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy-a retrospective study. Lung Cancer. 2012;78(2):148–52.PubMedCrossRef
3.
go back to reference Tournoy KG, Keller SM, Annema JT. Mediastinal staging of lung cancer: novel concepts. Lancet Oncol. 2012;13(5):e221–9.PubMedCrossRef Tournoy KG, Keller SM, Annema JT. Mediastinal staging of lung cancer: novel concepts. Lancet Oncol. 2012;13(5):e221–9.PubMedCrossRef
4.
go back to reference Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: risk factors, pattern, and histopathological study. Lung Cancer. 2011;71(3):333–7.PubMedCrossRef Kanzaki R, Higashiyama M, Fujiwara A, Tokunaga T, Maeda J, Okami J. Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: risk factors, pattern, and histopathological study. Lung Cancer. 2011;71(3):333–7.PubMedCrossRef
5.
go back to reference Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F. Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition). Chest. 2007;132(3):178–201.PubMedCrossRef Silvestri GA, Gould MK, Margolis ML, Tanoue LT, McCrory D, Toloza E, Detterbeck F. Noninvasive Staging of Non-small Cell Lung Cancer: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition). Chest. 2007;132(3):178–201.PubMedCrossRef
7.
go back to reference Gillies RJ, Kinahan PE, Hricak H. Radiomic: images are more than pictures, they are data. Radiology. 2015;278(2):563–77.PubMedCrossRef Gillies RJ, Kinahan PE, Hricak H. Radiomic: images are more than pictures, they are data. Radiology. 2015;278(2):563–77.PubMedCrossRef
8.
go back to reference Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30(9):1323–41.PubMedPubMedCentralCrossRef Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S. 3D slicer as an image computing platform for the quantitative imaging network. Magn Reson Imaging. 2012;30(9):1323–41.PubMedPubMedCentralCrossRef
9.
go back to reference Fave X, Mackin D, Yang JZ, Zhang J, Frid D, Balter P, Followill D. Can radiomic features be reproducibly measured from CBCT images for patients with non-small cell lung cancer? Med Phys. 2015;42(12):6784–97.PubMedPubMedCentralCrossRef Fave X, Mackin D, Yang JZ, Zhang J, Frid D, Balter P, Followill D. Can radiomic features be reproducibly measured from CBCT images for patients with non-small cell lung cancer? Med Phys. 2015;42(12):6784–97.PubMedPubMedCentralCrossRef
10.
go back to reference Goldstraw P, Chansky K, Crowley J. The IASLC lung Cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung Cancer. J Thorac Oncol. 2016;11(1):39–51.PubMedCrossRef Goldstraw P, Chansky K, Crowley J. The IASLC lung Cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung Cancer. J Thorac Oncol. 2016;11(1):39–51.PubMedCrossRef
11.
go back to reference Pisters KM, Darling G. The iaslc lung cancer staging project: “the nodal zone”. J Thorac Oncol. 2016;11(5):639–50.CrossRef Pisters KM, Darling G. The iaslc lung cancer staging project: “the nodal zone”. J Thorac Oncol. 2016;11(5):639–50.CrossRef
12.
go back to reference Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z, et al. Radiomic signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung Cancer. Radiology. 2016;281(3):947–57.PubMedCrossRef Huang Y, Liu Z, He L, Chen X, Pan D, Ma Z, et al. Radiomic signature: a potential biomarker for the prediction of disease-free survival in early-stage (I or II) non-small cell lung Cancer. Radiology. 2016;281(3):947–57.PubMedCrossRef
13.
go back to reference Liang W, He J, Shen Y, Shen J, He Q, Zhang J, et al. Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung Cancer: a population study of the US SEER database and a Chinese multi institutional registry. J Clin Oncol. 2017;35(11):1162–70.PubMedCrossRef Liang W, He J, Shen Y, Shen J, He Q, Zhang J, et al. Impact of examined lymph node count on precise staging and long-term survival of resected non-small-cell lung Cancer: a population study of the US SEER database and a Chinese multi institutional registry. J Clin Oncol. 2017;35(11):1162–70.PubMedCrossRef
14.
go back to reference Broderick SR, Patterson GA. Performance of integrated positron emission tomography/ computed tomography for mediastinal nodal staging in non-small cell lung carcinoma. Thorac Surg Clin. 2013;23(2):193–8.PubMedCrossRef Broderick SR, Patterson GA. Performance of integrated positron emission tomography/ computed tomography for mediastinal nodal staging in non-small cell lung carcinoma. Thorac Surg Clin. 2013;23(2):193–8.PubMedCrossRef
15.
go back to reference Liao CY, Chen JH, Liang JA, Yeh JJ, Kao CH. Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in nonsmall cell lung cancer: comparison of TB and non-TB endemic regions. Eur J Radiol. 2012;81(11):3518–23.PubMedCrossRef Liao CY, Chen JH, Liang JA, Yeh JJ, Kao CH. Meta-analysis study of lymph node staging by 18 F-FDG PET/CT scan in nonsmall cell lung cancer: comparison of TB and non-TB endemic regions. Eur J Radiol. 2012;81(11):3518–23.PubMedCrossRef
16.
go back to reference Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Víctor A, Marta Roqué I, Figuls MR. PET/CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;11(11):CD009519. Schmidt-Hansen M, Baldwin DR, Hasler E, Zamora J, Víctor A, Marta Roqué I, Figuls MR. PET/CT for assessing mediastinal lymph node involvement in patients with suspected resectable non-small cell lung cancer. Cochrane Database Syst Rev. 2014;11(11):CD009519.
17.
go back to reference Shao T, Yu LJ, Li Y, Chen M, Chen M, Petct M. Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer. Chin J Lung Cancer. 2015;18(2):155–60. Shao T, Yu LJ, Li Y, Chen M, Chen M, Petct M. Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer. Chin J Lung Cancer. 2015;18(2):155–60.
18.
go back to reference Bayanati H, E Thornhill R, Souza CA, Sethi-Virmani V, Gupta A, Maziak D. Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol. 2015;25(2):480–7.PubMedCrossRef Bayanati H, E Thornhill R, Souza CA, Sethi-Virmani V, Gupta A, Maziak D. Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol. 2015;25(2):480–7.PubMedCrossRef
19.
go back to reference Andersen MB, Harders SW, Ganeshan B, Thygesen J, Madsen HHT, Rasmussen F. CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer. Acta Radiol. 2016;57(6):669–76.PubMedCrossRef Andersen MB, Harders SW, Ganeshan B, Thygesen J, Madsen HHT, Rasmussen F. CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer. Acta Radiol. 2016;57(6):669–76.PubMedCrossRef
20.
go back to reference Pham TD, Watanabe Y, Higuchi M, Suzuki H. Texture analysis and synthesis of malignant and benign Mediastinal lymph nodes in patients with lung Cancer on computed tomography. Sci Rep. 2017;7:43209.PubMedPubMedCentralCrossRef Pham TD, Watanabe Y, Higuchi M, Suzuki H. Texture analysis and synthesis of malignant and benign Mediastinal lymph nodes in patients with lung Cancer on computed tomography. Sci Rep. 2017;7:43209.PubMedPubMedCentralCrossRef
21.
go back to reference Dong Y, Feng Q, Yang W, Lu Z, Deng C, Zhang L. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomic of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol. 2018;28(2):582–91.PubMedCrossRef Dong Y, Feng Q, Yang W, Lu Z, Deng C, Zhang L. Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomic of T2-weighted fat-suppression and diffusion-weighted MRI. Eur Radiol. 2018;28(2):582–91.PubMedCrossRef
22.
go back to reference Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X. Development and validation of a radiomic nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–64.PubMedCrossRef Huang YQ, Liang CH, He L, Tian J, Liang CS, Chen X. Development and validation of a radiomic nomogram for preoperative prediction of lymph node metastasis in colorectal cancer. J Clin Oncol. 2016;34(18):2157–64.PubMedCrossRef
23.
go back to reference Shen C, Liu Z, Wang Z, Guo J, Zhang H, Wang Y. Building CT Radiomic based Nomogram for preoperative esophageal Cancer patients lymph node metastasis prediction. Transl Oncol. 2018;11(3):815–24.PubMedPubMedCentralCrossRef Shen C, Liu Z, Wang Z, Guo J, Zhang H, Wang Y. Building CT Radiomic based Nomogram for preoperative esophageal Cancer patients lymph node metastasis prediction. Transl Oncol. 2018;11(3):815–24.PubMedPubMedCentralCrossRef
24.
go back to reference He L, Huang Y, Ma Z, et al. Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule. Sci Rep. 2016;6:34921.PubMedPubMedCentralCrossRef He L, Huang Y, Ma Z, et al. Effects of contrast-enhancement, reconstruction slice thickness and convolution kernel on the diagnostic performance of radiomics signature in solitary pulmonary nodule. Sci Rep. 2016;6:34921.PubMedPubMedCentralCrossRef
25.
go back to reference Sui H, Liu L, Li X, et al. CT-based radiomics features analysis for predicting the risk of anterior mediastinal lesions. J Thorac Dis. 2019;11(5):1809–18.PubMedPubMedCentralCrossRef Sui H, Liu L, Li X, et al. CT-based radiomics features analysis for predicting the risk of anterior mediastinal lesions. J Thorac Dis. 2019;11(5):1809–18.PubMedPubMedCentralCrossRef
26.
go back to reference Kim YK, Lee KS, Kim B-T, Choi JY, Kim H, Kwon OJ. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer. 2010;109(6):1068–77.CrossRef Kim YK, Lee KS, Kim B-T, Choi JY, Kim H, Kwon OJ. Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer. 2010;109(6):1068–77.CrossRef
27.
go back to reference Picozzi NM, Pillai P, Phillips R, Gupta U, Coulden R, Beadsmoore C. Can the negative predictive value of CT-PET for mediastinal lymph node staging in non-small cell lung cancer be trusted? Lung Cancer. 2008;60(8):S6.CrossRef Picozzi NM, Pillai P, Phillips R, Gupta U, Coulden R, Beadsmoore C. Can the negative predictive value of CT-PET for mediastinal lymph node staging in non-small cell lung cancer be trusted? Lung Cancer. 2008;60(8):S6.CrossRef
28.
go back to reference Thomas P, Abhishek M, Rikiya Y, Jayasree C, Tome S, William RJ. Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging. Abdo Radio. 2018;43(12):3271–8.CrossRef Thomas P, Abhishek M, Rikiya Y, Jayasree C, Tome S, William RJ. Short-term reproducibility of radiomic features in liver parenchyma and liver malignancies on contrast-enhanced CT imaging. Abdo Radio. 2018;43(12):3271–8.CrossRef
Metadata
Title
Discrimination of mediastinal metastatic lymph nodes in NSCLC based on radiomic features in different phases of CT imaging
Authors
Xue Sha
Guanzhong Gong
Qingtao Qiu
Jinghao Duan
Dengwang Li
Yong Yin
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Medical Imaging / Issue 1/2020
Electronic ISSN: 1471-2342
DOI
https://doi.org/10.1186/s12880-020-0416-3

Other articles of this Issue 1/2020

BMC Medical Imaging 1/2020 Go to the issue